Topper Copies

In a capitalist market, the goal of a business is to sell a product to satisfy demand. In this context, a company's objective is to maximize profits. However, there are industries where the social good should take precedence over profits and the pharmaceutical Industry is an example of such an industry. Recently, an incident of arbitrary pricing by a pharmaceutical company has come to light. After years of research, the concerned company released a medicine for the treatment of a rare disease. It holds the patent for the medicine and has spent considerable R&D resources to produce the medicine. But the extraordinarily high price it has fixed for the medicine has not only dashed the hopes of patients suffering from the rare disease but has also shocked the conscience of the public at large. However, there are also some who are arguing that forcing the company to cap the price of the medicine will disincentivise pharmaceutical firms to conduct research and produce treatments for rare diseases in the future. In this context, answer the following: (a) What are the various issues in the above situation? (b) Do you think a price-cap solves the given problem by creating another one? (c) What are the long-term measures that can be taken to deal with issues arising in such cases?

Pakshal Secretry, AIR 8, 2025

"Commerce without Morality" is a social sin, as identified by Gandhiji.

The above case relates to profit consideration of a company in conflict with larger societal interest, similar to the recent case of the TB Bedaquiline tablet Johnson controversy.

a) Issues Involved i. High price charged by the company ii. Profit consideration of the firm iii. Access to treatment for a rare disease iv. Incentivising R&D expenditure by pharma firms v. Interference of the State in the market economy vi. Affordability of treatment to the most vulnerable section

b) Does a price cap solve the current problem, or create another?

Price cap solves the current problem i. Price cap would result in affordability of medicine to the patient ii. It will benefit the most vulnerable section to the largest extent (supported by Rawls's social justice idea) iii. Ensures maximum good to maximum people (Teleological Approach) iv. Will also benefit society at large

Creating another problem i. Will disincentivise the pharma company from conducting R&D, and thus society will suffer in the long term ii. Interference of the state will create market distortion (Adam Smith) and lead to deadweight loss iii. Price cap will result in hoarding and black marketing of the product, thus informally impacting the vulnerable section the most iv. This price cap will also be a violation of IPR commitment at the WTO, and will discourage investment in India

c) Long term measures i. State can provide a subsidy to pharma companies to incentivise R&D - done in India to develop the Covid-19 vaccine ii. Ensuring morality in business by inculcating values in commerce iii. Compulsory licensing after a certain period, to allow development of generic drugs once the company recovers its cost iv. Providing health and treatment by the state to the most vulnerable - Ayushman Bharat scheme

The pharma companies must understand the concerns of society and thus change price only to recover costs.